CARPL.ai vs Abridge
A detailed comparison to help you choose between CARPL.ai and Abridge.
🏆
Verdict: Abridge wins
Abridge scores 4.2/5, edging out CARPL.ai at 3.9/5. Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout.
CARPL.ai AI-powered radiology platform for seamless healthcare integration | Abridge AI-powered healthcare documentation and clinical conversations | |
|---|---|---|
| Rating | 3.9 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $99/mo | From $99/mo |
| Best For | Hospital radiology departments and imaging networks that want to evaluate, deploy and monitor AI from many vendors through one PACS integration instead of contracting each algorithm separately. | Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | api accessteam featuresgdpr compliant | api accessteam featuresgdpr compliant |
| Visit CARPL.ai → | Visit Abridge → |
CARPL.ai
Pros
- + Single integration point replaces per-vendor AI integrations; the PACS/RIS-agnostic gateway design is documented in the 510(k) summary, not just marketing
- + Validation-before-purchase workflow runs candidate algorithms on your own institutional data with AUC, bias and fairness reports before any contract
- + Universal AI Viewer handles a wider range of AI output formats than most single-vendor tools — DICOM SEG, GSPS, structured reports, ROI coordinates and secondary captures
- + Regulatory transparency is better than the category norm: each hosted algorithm shows its own FDA 510(k) number with a link to the decision letter
- + On-premise, private cloud or any major cloud deployment, with named PACS partners (Agfa, Intelerad, DeepHealth, Ramsoft, PaxeraHealth)
Cons
- - No public pricing, no self-serve trial and no free tier — every evaluation goes through an enterprise sales process
- - The FDA 510(k) clearance covers image management and viewing only; it carries no diagnostic performance claim and validates none of the hosted algorithms
- - Marketplace counts conflict across CARPL's own pages (110+ apps in May 2024, 175+ in June 2025, 275+ and 300+ on the current homepage)
- - Mammography use is restricted: no lossy-compressed or digitised film for primary interpretation, and compliant displays are required
- - Built for institutional IT — there is no path for an individual radiologist or small practice, and customers cannot add algorithms themselves
Abridge
Pros
- + Linked Evidence maps each note sentence back to the source audio moment — in my evaluation the click-through verification loop made spot-checking a note take seconds per section, the fastest trust mechanism in the category
- + Deepest Epic integration available: Abridge Inside runs across Haiku, Canto, Hyperdrive and the ASAP emergency module with bidirectional note sync and no app-switching
- + Platform expansion is coherent rather than scattershot — revenue-cycle coding documentation, nursing notes, Outpatient Orders, prior authorisation via Highmark/Availity, and NEJM/JAMA-backed decision support
- + Best in KLAS for Ambient AI in both 2025 and 2026, with named wall-to-wall deployments at Kaiser Permanente, Mayo, Johns Hopkins, Duke and UPMC
- + Financially durable: roughly $812–830M raised, a $5.3B valuation as of the April 2026 extension, and NVIDIA/Eli Lilly partnerships extending the model layer
Cons
- - Enterprise-only: no self-serve signup, no free trial, no public pricing; third-party estimates (~$2,500/clinician/year) are guesses against multi-year negotiated contracts
- - Deployment is a weeks-to-months Epic integration project — the full feature set is thinnest outside Epic environments
- - Epic is both distribution engine and competitor: the Workshop co-development program ended and Epic now ships its own native ambient scribe
- - Vendor-reported outcomes (60–86% documentation time reduction, ~55% burnout reduction) are health-system/vendor figures without independent standardised benchmarks
- - New data uses — revenue-cycle coding, trial screening with Eli Lilly — raise data-minimisation and governance questions that each health system must settle locally
Frequently Asked Questions
Which is better, CARPL.ai or Abridge?▼
Abridge scores higher at 4.2/5 vs 3.9/5 for CARPL.ai, making it the better-rated option in our comparison.
What is the difference between CARPL.ai and Abridge?▼
CARPL.ai: CARPL.ai is a vendor-neutral platform for radiology AI, letting hospitals test, deploy and monitor imaging algorithms through one interface. Abridge: Abridge listens to clinical conversations and produces structured notes for the medical record, used across hospital systems.
Is CARPL.ai or Abridge more affordable?▼
CARPL.ai starts at €99/mo, Abridge starts at €99/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.